Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Now watching

Next video starts in : 7 Play

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People
Replay video
Up next

HP Details Company Split; Gap Struggles to Rekindle Brand Interest

Unlock your personal NFL Now stream by signing in to NFL.com

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

by TheStreet 1:02 mins

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

by TheStreet 1:02 mins

New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York.

TheStreet

Personal Finance

  1. 2:23

    3 strategies that can help simplify your life

  2. 2:14

    Would you give your dog your kidney?

  3. 2:14

    5 unique summer jobs that pay great

  4. 1:03

    Money Minute: What employers are really looking for

  5. 2:31

    CEO cashes out to become a farmer

  6. 2:39

    Meet "The Contest Queen" who won over $250,000 in prizes

Market Movers